Sagimet Biosciences Inc
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Sagimet Biosciences Inc
Sagimet Biosciences Inc is a clinical-stage biopharmaceutical company dedicated to developing a portfolio of in-house discovered, selective fatty acid synthase (FASN) inhibitors aimed at treating diseases that arise from dysfunctional lipid metabolism pathways. The company's drug candidate, denifanstat, is an oral, once-daily pill that serves as a selective FASN inhibitor under development for treating nonalcoholic steatohepatitis (NASH). The company functions as a single business segment, focusing on the development and commercialization of therapeutics for MASH and other diseases where FASN plays a pathogenic role.
/ 
Frequently asked questions
To buy Sagimet Biosciences Inc stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Sagimet Biosciences Inc by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Sagimet Biosciences Inc is SGMT:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Sagimet Biosciences Inc has its primary listing on NASDAQ. You can trade Sagimet Biosciences Inc with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Sagimet Biosciences Inc is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Sagimet Biosciences Inc as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Sagimet Biosciences Inc.